Although TGFβ did not affect the number of tumor-infiltrating macrophages (TAMs) in primary or metastatic tumors, TGFβ treatment enhanced the percent of TAMs positive for PD-L1 [169]. This evidence concerns the gene CD274 and neoplasm.